Dechra Pharmaceuticals Plc engages in the veterinary pharmaceuticals and relates products business. The company operates through three segments: European Pharmaceuticals, North American Pharmaceuticals and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed branded pharmaceuticals and specialist pet foods to the veterinary profession in Europe. It is a licensed manufacturer of both Dechra's own branded products and products for third party customers. The North American Pharmaceuticals segment markets and sells a range of endocrine, ophthalmic, dermatological and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. Dechra Pharmaceuticals was founded in May 13,1997 and is headquartered in Northwich, the United Kingdom.